CARLIER, Jeremy
 Distribuzione geografica
Continente #
NA - Nord America 5.036
AS - Asia 1.864
EU - Europa 1.589
SA - Sud America 316
Continente sconosciuto - Info sul continente non disponibili 182
AF - Africa 128
OC - Oceania 13
Totale 9.128
Nazione #
US - Stati Uniti d'America 4.909
SG - Singapore 551
IT - Italia 511
CN - Cina 330
VN - Vietnam 329
RU - Federazione Russa 268
HK - Hong Kong 245
BR - Brasile 229
IE - Irlanda 128
SE - Svezia 123
GB - Regno Unito 106
DE - Germania 105
FR - Francia 105
BD - Bangladesh 96
IN - India 83
CA - Canada 59
NL - Olanda 56
MX - Messico 46
CI - Costa d'Avorio 42
FI - Finlandia 37
JP - Giappone 35
AR - Argentina 25
IQ - Iraq 25
TR - Turchia 25
PL - Polonia 24
BE - Belgio 23
ID - Indonesia 22
ES - Italia 19
ZA - Sudafrica 19
PK - Pakistan 17
AT - Austria 16
KR - Corea 16
EC - Ecuador 15
MA - Marocco 15
PH - Filippine 14
TH - Thailandia 12
UA - Ucraina 12
VE - Venezuela 12
KE - Kenya 11
RO - Romania 11
CO - Colombia 10
EG - Egitto 10
LT - Lituania 10
AU - Australia 9
CL - Cile 9
IR - Iran 8
SA - Arabia Saudita 8
JM - Giamaica 7
JO - Giordania 7
TN - Tunisia 7
DZ - Algeria 6
NG - Nigeria 6
TW - Taiwan 6
AE - Emirati Arabi Uniti 5
CH - Svizzera 5
GH - Ghana 5
PE - Perù 5
IL - Israele 4
MY - Malesia 4
NZ - Nuova Zelanda 4
OM - Oman 4
UY - Uruguay 4
BY - Bielorussia 3
CZ - Repubblica Ceca 3
GR - Grecia 3
MD - Moldavia 3
PT - Portogallo 3
PY - Paraguay 3
UZ - Uzbekistan 3
AL - Albania 2
BO - Bolivia 2
CR - Costa Rica 2
ET - Etiopia 2
GY - Guiana 2
HN - Honduras 2
KH - Cambogia 2
MK - Macedonia 2
ML - Mali 2
NP - Nepal 2
PS - Palestinian Territory 2
SK - Slovacchia (Repubblica Slovacca) 2
TT - Trinidad e Tobago 2
AZ - Azerbaigian 1
BB - Barbados 1
BH - Bahrain 1
BN - Brunei Darussalam 1
DK - Danimarca 1
DM - Dominica 1
DO - Repubblica Dominicana 1
EE - Estonia 1
EU - Europa 1
GE - Georgia 1
GP - Guadalupe 1
GT - Guatemala 1
HT - Haiti 1
HU - Ungheria 1
IM - Isola di Man 1
KG - Kirghizistan 1
KW - Kuwait 1
KZ - Kazakistan 1
Totale 8.934
Città #
Ashburn 1.034
Dallas 590
Singapore 304
Chandler 282
San Jose 275
Hong Kong 230
Council Bluffs 146
Dublin 125
Los Angeles 123
The Dalles 114
Boardman 106
Des Moines 106
Ho Chi Minh City 105
New York 104
Beijing 100
Hanoi 76
Fairfield 75
Lauterbourg 63
Moscow 50
Ancona 47
Milan 45
Chicago 44
Santa Clara 43
Abidjan 42
Lawrence 40
Princeton 40
Rome 40
Denver 39
Seattle 39
Atlanta 35
San Francisco 35
Houston 34
Munich 34
Orem 33
Phoenix 31
Turin 30
São Paulo 28
London 27
Woodbridge 27
Buffalo 26
Tokyo 26
Washington 25
Cambridge 23
Jacksonville 22
Montreal 22
Warsaw 21
Brussels 19
Frankfurt am Main 19
Helsinki 19
Columbus 18
Hefei 18
Da Nang 17
Turku 17
Wilmington 17
Brooklyn 16
Chennai 16
Boston 15
Haiphong 15
Mexico City 15
Amsterdam 13
San Diego 13
Shanghai 13
Tolentino 13
Poplar 12
Baghdad 11
San Mateo 11
Shenzhen 11
Nairobi 10
Toronto 10
Vienna 10
Johannesburg 9
Naples 9
Nuremberg 9
Pune 9
Salt Lake City 9
Ann Arbor 8
Elk Grove Village 8
Querétaro 8
Rancho Palos Verdes 8
Stockholm 8
Verona 8
Amman 7
Ankara 7
Boydton 7
Guangzhou 7
Manchester 7
Palermo 7
Quito 7
City of London 6
Detroit 6
Goiânia 6
Memphis 6
Miami 6
Seoul 6
Accra 5
Ahmedabad 5
Biên Hòa 5
Bologna 5
Brisbane 5
Buenos Aires 5
Totale 5.462
Nome #
UHPLC-MS-MS Determination of THC, CBD and Their Metabolites in Whole Blood of Light Cannabis Smokers 557
Chlorthalidone In Vitro Metabolite Identification for Documenting Exposure in Doping 295
Protodioscin, a natural saponin with potential steroidogenic effects: metabolic and analytical considerations 274
Human diagnostic markers for intake of semi-synthetic cannabinoids (9R)- and (9S)-hexahydrocannabinol 238
Human metabolism and pharmacological profiling of protonitazepyne and metonitazepyne, two highly potent nitazenes: prediction of main metabolite activity based on µ-opioid receptor docking simulations 224
Drug-facilitated sexual assaults (DFSA): A serious underestimated issue 209
In silico and in vitro human metabolism of IOX2, a performance-enhancing doping agent 187
Human metabolism of four synthetic benzimidazole opioids: isotonitazene, metonitazene, etodesnitazene, and metodesnitazene 180
New challenges in clinical and forensic toxicology 180
Pharmacology of herbal sexual enhancers: A review of psychiatric and neurological adverse effects 176
Quantification of pregabalin using hydrophilic interaction hplc-high-resolution ms in postmortem human samples: Eighteen case reports 172
3-CMC, 4-CMC, and 4-BMC Human Metabolic Profiling: New Major Pathways to Document Consumption of Methcathinone Analogues? 166
Disposition of Hexahydrocannabinol Epimers and Their Metabolites in Biological Matrices following a Single Administration of Smoked Hexahydrocannabinol: A Preliminary Study 165
Acute Intoxications and Fatalities Associated with Benzimidazole Opioid (Nitazene Analog) Use: A Systematic Review 165
“Tranq-dope”: The first fatal intoxication due to xylazine-adulterated heroin in Italy 158
In silico prediction, LC-HRMS/MS analysis, and targeted/untargeted data-mining workflow for the profiling of phenylfentanyl in vitro metabolites 158
Monitoring Prenatal Exposure to Buprenorphine and Methadone 152
The principal toxic glycosidic steroids in Cerbera manghas L. seeds: Identification of cerberin, neriifolin, tanghinin and deacetyltanghinin by UHPLC-HRMS/MS, quantification by UHPLC-PDA-MS 150
A 2017-2019 Update on Acute Intoxications and Fatalities from Illicit Fentanyl and Analogs 143
Pyrrolidinyl synthetic cathinones α-php and 4f-α-pvp metabolite profiling using human hepatocyte incubations 142
Dipyanone, a new methadone-like synthetic opioid: In vitro and in vivo human metabolism and pharmacological profiling 141
Use of cognitive enhancers: Methylphenidate and analogs 140
β'-Phenylfentanyl Metabolism in Primary Human Hepatocyte Incubations: Identification of Potential Biomarkers of Exposure in Clinical and Forensic Toxicology 138
Exploring the Metabolism of Flubrotizolam, a Potent Thieno-Triazolo Diazepine, Using Human Hepatocytes and High-Resolution Mass Spectrometry 137
Testing Unconventional Matrices to Monitor for Prenatal Exposure to Heroin, Cocaine, Amphetamines, Synthetic Cathinones, and Synthetic Opioids 137
In vitro, in vivo metabolism and quantification of the novel synthetic opioid N-piperidinyl etonitazene (etonitazepipne) 136
3F-α-pyrrolydinovalerophenone (3F-α-PVP) in vitro human metabolism: Multiple in silico predictions to assist in LC-HRMS/MS analysis and targeted/untargeted data mining 132
Consequences of COVID-19 Lockdown on the Misuse and Marketing of Addictive Substances and New Psychoactive Substances 132
QuEChERS Extraction and Simultaneous Quantification in GC-MS/MS of Hexahydrocannabinol Epimers and Their Metabolites in Whole Blood, Urine, and Oral Fluid 130
In Vitro and In Vivo Human Metabolism of Ostarine, a Selective Androgen Receptor Modulator and Doping Agent 129
Advances in forensic toxicology 123
Ultra-high-performance liquid chromatography-tandem mass spectrometry assay for quantifying fentanyl and 22 analogs and metabolites in whole blood, urine, and hair 122
Biomarkers of 4-hydroxy-N,N-methylpropyltryptamine (4-OH-MPT) intake identified from human hepatocyte incubations 119
Monitoring Perinatal Exposure to Cannabis and Synthetic Cannabinoids 117
Cannabidiol adverse effects and toxicity 116
Distinguishing intake of new synthetic cannabinoids ADB-PINACA and 5F-ADB-PINACA with human hepatocyte metabolites and high-resolution mass spectrometry 114
Development of an enantioselective high-performance liquid chromatography-tandem mass spectrometry method for the quantitative determination of methorphan and its O-demethylated metabolite in human blood and its application to post-mortem samples 112
Quantification of Carbonic Anhydrase Inhibitors and Metabolites in Urine and Hair of Patients and Their Relatives 111
Metabolism Study of Anamorelin, a GHSR1a Receptor Agonist Potentially Misused in Sport, with Human Hepatocytes and LC-HRMS/MS 111
Measurement uncertainty in forensic toxicology 111
In silico, in vitro, and in vivo human metabolism of acetazolamide, a carbonic anhydrase inhibitor and common “diuretic and masking agent” in doping 102
Fatal intoxication due to ackee (Blighia sapida) in Suriname and French Guyana. GC-MS detection and quantification of hypoglycin-A 102
Fatal intoxication after taking iboga: GC-MS/MS determination of ibogaine and ibogamine in iboga roots and post-mortem material 100
Synthetic cannabinoid BB-22 (QUCHIC): Human hepatocytes metabolism with liquid chromatography-high resolution mass spectrometry detection 100
In vivo and in vitro metabolism of the designer benzodiazepine, bretazenil: a comparison of pooled human hepatocytes and liver microsomes with postmortem urine and blood samples 99
A validated method for quantifying hypoglycin A in whole blood by UHPLC-HRMS/MS 97
In vitro and in vivo human metabolism of a new synthetic cannabinoid NM-2201 (CBL-2201) 92
In vitro metabolite profiling of ADB-FUBINACA, a new synthetic cannabinoid 92
Identification of alexamorelin consumption biomarkers using human hepatocyte incubations and high-resolution mass spectrometry 91
Update on Cannabidiol Clinical Toxicity and Adverse Effects: a Systematic Review 90
25C-NBOMe and 25I-NBOMe metabolite studies in human hepatocytes, in vivo mouse and human urine with high-resolution mass spectrometry 90
Human Hepatocyte 4-Acetoxy-N,N-Diisopropyltryptamine Metabolite Profiling by Reversed-Phase Liquid Chromatography Coupled with High-Resolution Tandem Mass Spectrometry 88
A validated method for quantifying atractyloside and carboxyatractyloside in blood by hplc-hrms/ms, a non-fatal case of intoxication with atractylis gummifera l 88
α-Methyltryptamine (α-MT) Metabolite Profiling in Human Hepatocyte Incubations and Postmortem Urine and Blood 87
Metabolism and detection of designer benzodiazepines: a systematic review 87
Atropine eye drops: An unusual homicidal poisoning 86
Pharmacodynamic effects, pharmacokinetics, and metabolism of the synthetic cannabinoid AM-2201 in male rats 84
Identification of New Synthetic Cannabinoid ADB-CHMINACA (MAB-CHMINACA) Metabolites in Human Hepatocytes 82
Human hepatocyte metabolism of novel synthetic cannabinoids MN-18 and its 5-fluoro analog 5F-MN-18 82
Fatal case of a 27-year-old male after taking iboga in withdrawal treatment: GC-MS/MS determination of ibogaine and ibogamine in iboga roots and postmortem biological material 80
Screening approach by ultra-high performance liquid chromatography-tandem mass spectrometry for the blood quantification of thirty-four toxic principles of plant origin. Application to forensic toxicology 76
Quantification of [1-(5-fluoropentyl)-1H-indol-3-yl](naphthalene-1-yl)methanone (AM-2201) and 13 metabolites in human and rat plasma by liquid chromatography-tandem mass spectrometry 73
Comparison of authentic urine N-ethylpentedrone metabolites to predicted in silico and in vitro human hepatocyte metabolism 67
In vitro, in vivo and in silico metabolic profiling of α-pyrrolidinopentiothiophenone, a novel thiophene stimulant 67
Insights into the human metabolism and in silico receptor activity of gidazepam and desalkylgidazepam 63
In vitro metabolism of new synthetic cannabinoid SDB-006 in human hepatocytes by high-resolution mass spectrometry 61
Metabolism of the new synthetic cannabinoid EG-018 in human hepatocytes by high-resolution mass spectrometry 61
Synthetic cannabinoids: Analytical methods 55
In Vitro Metabolism of a Benzofuran-Substituted Nitazene: Ethyleneoxynitazene 54
Quantification of hypoglycin A in serum using aTRAQ® assay 50
Structure-activity relationship of prevalent synthetic cannabinoid metabolites on hCB1 in vitro and in silico dynamics 44
Synthetic cannabinoid receptor agonists containing silicon: exploring the metabolic pathways of ADMB- and Cumyl-3TMS-PrINACA in human urine specimens and post mortem material compared to in vitro and in silico data 39
Totale 9.128
Categoria #
all - tutte 37.552
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 37.552


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022235 0 16 2 2 1 15 4 7 14 18 94 62
2022/2023824 57 95 49 77 51 182 2 54 178 7 46 26
2023/2024543 65 19 78 75 91 83 17 15 4 21 24 51
2024/20251.376 101 93 26 49 78 73 164 64 206 149 197 176
2025/20264.698 269 584 287 397 449 226 831 398 379 394 243 241
2026/20271.253 584 669 0 0 0 0 0 0 0 0 0 0
Totale 9.128